Your browser doesn't support javascript.
loading
Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real-World Population.
Oni-Orisan, Akinyemi; Haldar, Tanushree; Cayabyab, Mari A S; Ranatunga, Dilrini K; Hoffmann, Thomas J; Iribarren, Carlos; Krauss, Ronald M; Risch, Neil.
Affiliation
  • Oni-Orisan A; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Haldar T; Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.
  • Cayabyab MAS; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Ranatunga DK; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Hoffmann TJ; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Iribarren C; Kaiser Permanente Division of Research, Oakland, California, USA.
  • Krauss RM; Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.
  • Risch N; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Clin Pharmacol Ther ; 112(5): 1070-1078, 2022 11.
Article in En | MEDLINE | ID: mdl-35862449
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Coronary Disease / Atherosclerosis / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Coronary Disease / Atherosclerosis / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: